Thomas A. Russo

13.8k citations

126 papers · 9.3k indexed · 5 hit papers · h-index 54

Impact in

Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria
Endocrinology top 0.02%
- Escherichia coli research studies
- Vibrio bacteria research studies
- Enterobacteriaceae and Cronobacter Research

Papers in

Molecular Medicine 73
- Antibiotic Resistance in Bacteria 73
Endocrinology 61
- Escherichia coli research studies 45
- Vibrio bacteria research studies 18
- Enterobacteriaceae and Cronobacter Research 10

Co-authors: James R. Johnson Ulrike MacDonald Alyssa Shon Rajinder Bajwa Ruth Olson Janet M. Beanan Ulrike B. Carlino Anthony A. Campagnari
Journals: Infection and Immunity (23 papers)The Journal of Infectious Diseases (12 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (6 papers)Journal of Bacteriology (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)
Partner nations: United States Canada Australia

In The Last Decade

Thomas A. Russo

123 papers receiving 9.1k citations

Hit Papers

5 papers align trajectories log scale

Differentiation of hypervirulent and classical Klebsiella pneumoniae with acquired drug resistance 2024 · 52 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 mBio
2019 Clinical Microbiology Reviews
2013 Virulence
2003 Microbes and Infection
2000 The Journal of Infectious Diseases

Peers

Countries citing papers authored by Thomas A. Russo

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Russo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Russo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Russo more than expected).

Fields of papers citing papers by Thomas A. Russo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Russo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Russo. The network helps show where Thomas A. Russo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas A. Russo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas A. Russo Line = papers co-authored together Thomas A. Russo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Acinetobacter baumannii Clinical Isolates Resist Complement-Mediated Lysis by Inhibiting the Complement Cascade and Improperly Depositing MAC Journal of Innate Immunity ·Zinaida Gineitienė, 杨跃, Serena Bettoni, Derek Fairley, Thomas A. Russo, Christian G. Giske, Chaitanya Tellapragada, Suzan H. M. Rooijakkers, Kristian Riesbeck, Anna M. Blom	2025	0
2	Genomic and phylogenetic analysis of hypervirulent Klebsiella pneumoniae ST23 in Ireland Microbial Genomics ·誠樹児玉, Niall DeLappe, Yeim Dufranny Narváez Vargas, Paula Twardowska, Ulrike MacDonald, Alan D. Hutson, Martin Cormican, Gamboa Córdova, Florinda Renda Maria Langitan, Dearbháile Morris, Suzie Coughlan, Marita Lynagh, Thomas A. Russo, Liam P. Burke	2025	3
3	Metastatic infection of hypervirulent Klebsiella pneumoniae IDCases ·Shuijian Feng, Chao Liu, 唐筱扬, Thomas A. Russo, Ming Lu	2024	0
4	Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System Frontiers in Immunology ·Zinaida Gineitienė, Serena Bettoni, Maisem Laabei, Derek Fairley, Thomas A. Russo, Kristian Riesbeck, Anna M. Blom	2022	11
5	Capsule carbohydrate structure determines virulence in Acinetobacter baumannii PLoS Pathogens ·BingNan Liao, Travis B. Nielsen, Jun Yan, Ulrike MacDonald, Gisela Di Venanzio, Somnath Chakravorty, 辛玉欣, Mario F. Feldman, Thomas A. Russo, Evgeny Vinogradov, Brian Luna, Meredith S. Wright, Mark D. Adams, Brad Spellberg	2021	72
6	“You have to believe in something”: Risk of psychosis and psychiatrists’ beliefs in the self-fulfilling prophecy Social Science & Medicine ·Laelia Benoit, Thomas A. Russo, Caroline Barry, Bruno Falissard, Credit Emily Hoyer	2019	10
7	Crystal structure of 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase from the ESKAPE pathogenAcinetobacter baumannii Acta Crystallographica Section F Structural Biology Communications ·V.W. Bradshaw, Toh Hiroyuki, Thomas A. Russo, L. Wayne Schultz, Timothy C. Umland	2016	16
8	Draft Genome Sequence of the Hypervirulent Klebsiella pneumoniae Strain hvKP1, Isolated in Buffalo, New York Genome Announcements ·Thomas A. Russo, Steven R. Gill	2013	20
9	OxyR contributes to the virulence of a Clonal Group A Escherichia coli strain (O17:K+:H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsis Microbial Pathogenesis ·James R. Johnson, Thomas A. Russo, Sarah M. Drawz, Connie Clabots, Ruth Olson, Michael A. Kuskowski, Henry Rosen	2013	14
10	Hypervirulent (hypermucoviscous)Klebsiella pneumoniae Virulence ·Alyssa Shon, Rajinder Bajwa, Thomas A. Russo Hit paper breakdown →	2013	872
11	In Vivo -Validated Essential Genes Identified in Acinetobacter baumannii by Using Human Ascites Overlap Poorly with Essential Genes Detected on Laboratory Media mBio ·Timothy C. Umland, L. Wayne Schultz, Ulrike MacDonald, Janet M. Beanan, Ruth Olson, Thomas A. Russo	2012	70
12	Surfactant dysfunction and lung injury due to theE. colivirulence factor hemolysin in a rat pneumonia model American Journal of Physiology-Lung Cellular and Molecular Physiology ·Thomas A. Russo, Zhengdong Wang, Bruce A. Davidson, Lian qinhan, Janet M. Beanan, Ruth Olson, Bruce A. Holm, Paul R. Knight, Patricia R. Chess, Robert H. Notter	2007	19
13	A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate Vaccine ·Thomas A. Russo, Janet M. Beanan, Ruth Olson, Lian qinhan, Ulrike MacDonald, John J. Cope, Bruce A. Davidson, Brian Johnston, James R. Johnson	2007	27
14	The effects ofEscherichia colicapsule, O-antigen, host neutrophils, and complement in a rat model of Gram-negative pneumonia FEMS Microbiology Letters ·Thomas A. Russo, Bruce A. Davidson, Ulrike MacDonald, Jadwiga D. Helinski, Roger L. Priore, Paul R. Knight	2003	19
15	UropathogenicEscherichia colias Agents of Diverse Non–Urinary Tract Extraintestinal Infections The Journal of Infectious Diseases ·James R. Johnson, Thomas A. Russo	2002	67
16	Molecular Comparison of ExtraintestinalEscherichia coliIsolates of the Same Electrophoretic Lineages from Humans and Domestic Animals The Journal of Infectious Diseases ·James R. Johnson, Parissa Delavari, Adam L. Stell, Thomas S. Whittam, Ulrike B. Carlino, Thomas A. Russo	2001	53
17	The Presence of K54 Capsular Polysaccharide Increases the Pathogenicity of Escherichia coli In Vivo The Journal of Infectious Diseases ·Thomas A. Russo, Yuan Liang, Alan S. Cross	1994	44
18	Regulation of the commodities, futures and options market Thomas A. Russo	1985	3
19	Regulation of brokers, dealers, and securities markets Є. І. Бисага, 田绪军, Thomas A. Russo	1977	3
20	The Structure of the Securities Market - Past and Future Fordham law review ·Thomas A. Russo, Karoline Victoria Esteves da Silva	1972	1

About Thomas A. Russo

Thomas A. Russo is a scholar working on Molecular Medicine, Endocrinology, Microbiology, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 126 papers that have together received 9.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (73 papers), Escherichia coli research studies (45 papers), Pneumonia and Respiratory Infections (21 papers), Vibrio bacteria research studies (18 papers), Bacterial Genetics and Biotechnology (18 papers), Enterobacteriaceae and Cronobacter Research (10 papers), Urinary Tract Infections Management (8 papers) and Bacteriophages and microbial interactions (7 papers). The work is most often cited by research in Molecular Medicine (5.4k citations), Endocrinology (4.7k citations), Applied Microbiology and Biotechnology (218 citations), Clinical Biochemistry (624 citations) and Microbiology (547 citations). Thomas A. Russo has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include James R. Johnson, Ulrike MacDonald, Alyssa Shon, Rajinder Bajwa, Ruth Olson, Janet M. Beanan, Ulrike B. Carlino, Anthony A. Campagnari, Bruce A. Davidson and Ann E. Stapleton. Their work appears in journals such as Infection and Immunity, The Journal of Infectious Diseases, American Journal of Physiology-Lung Cellular and Molecular Physiology, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact